These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38076440)

  • 41. Natural history of NASH cirrhosis in liver transplant waitlist registrants.
    Lim WH; Ng CH; Tan D; Tseng M; Xiao J; Yong JN; Zeng RW; Cho E; Tay P; Ang CZ; Koh JH; Teng M; Syn N; Kow A; Huang DQ; Tan EX; Rinella ME; Sanyal A; Muthiah M; Siddiqui MS
    J Hepatol; 2023 Oct; 79(4):1015-1024. PubMed ID: 37307997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-alcoholic fatty liver disease and liver transplantation.
    Khan RS; Newsome PN
    Metabolism; 2016 Aug; 65(8):1208-23. PubMed ID: 26997540
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients.
    Su R; Wei X; Wei Q; Lu D; Lin Z; Wang S; Shao C; Xu X
    Hepatobiliary Surg Nutr; 2022 Jun; 11(3):400-411. PubMed ID: 35693397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease.
    Zachou K; Azariadis K; Lytvyak E; Snijders RJALM; Takahashi A; Gatselis NK; Robles M; Andrade RJ; Schramm C; Lohse AW; Tanaka A; Drenth JPH; Montano-Loza AJ; Dalekos GN;
    JHEP Rep; 2023 Aug; 5(8):100778. PubMed ID: 37456672
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease.
    Khullar V; Dolganiuc A; Firpi RJ
    World J Transplant; 2014 Jun; 4(2):81-92. PubMed ID: 25032097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates .
    Samji NS; Heda R; Satapathy SK
    Transl Gastroenterol Hepatol; 2020; 5():10. PubMed ID: 32190778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recurrence of graft steatosis after liver transplantation for cryptogenic cirrhosis in recently commenced liver transplant program.
    Siriwardana RC; Niriella MA; Dassanayake AS; Liyanage CA; Gunetilleke B; de Silva HJ
    Indian J Gastroenterol; 2016 May; 35(3):222-4. PubMed ID: 27142096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Portal Hypertension Complications Are Frequently the First Presentation of NAFLD in Patients Undergoing Liver Transplantation Evaluation.
    Nagpal SJ; Kabbany MN; Mohamad B; Lopez R; Zein NN; Alkhouri N
    Dig Dis Sci; 2016 Jul; 61(7):2102-7. PubMed ID: 26993824
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of post-transplant diabetes mellitus on liver transplant outcomes.
    Lieber SR; Lee RA; Jiang Y; Reuter C; Watkins R; Szempruch K; Gerber DA; Desai CS; DeCherney GS; Barritt AS
    Clin Transplant; 2019 Jun; 33(6):e13554. PubMed ID: 30927288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.
    Maliakkal BJ
    Transl Gastroenterol Hepatol; 2020; 5():36. PubMed ID: 32632387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk Factors and Clinical Course for Liver Steatosis or Nonalcoholic Steatohepatitis After Living Donor Liver Transplantation.
    Miyaaki H; Miuma S; Taura N; Shibata H; Sasaki R; Soyama A; Hidaka M; Takatsuki M; Eguchi S; Nakao K
    Transplantation; 2019 Jan; 103(1):109-112. PubMed ID: 29894414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD14 upregulation as a distinct feature of non-alcoholic fatty liver disease after pancreatoduodenectomy.
    Satoh D; Yagi T; Nagasaka T; Shinoura S; Umeda Y; Yoshida R; Utsumi M; Tanaka T; Sadamori H; Fujiwara T
    World J Hepatol; 2013 Apr; 5(4):189-95. PubMed ID: 23671723
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
    Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry.
    Younossi ZM; Yilmaz Y; Yu ML; Wai-Sun Wong V; Fernandez MC; Isakov VA; Duseja AK; Mendez-Sanchez N; Eguchi Y; Bugianesi E; Burra P; George J; Fan JG; Papatheodoridis GV; Chan WK; Alswat K; Saeed HS; Singal AK; Romero-Gomez M; Gordon SC; Roberts SK; El Kassas M; Kugelmas M; Ong JP; Alqahtani S; Ziayee M; Lam B; Younossi I; Racila A; Henry L; Stepanova M;
    Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2296-2306.e6. PubMed ID: 34768009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".
    Dumortier J; Giostra E; Belbouab S; Morard I; Guillaud O; Spahr L; Boillot O; Rubbia-Brandt L; Scoazec JY; Hadengue A
    Am J Gastroenterol; 2010 Mar; 105(3):613-20. PubMed ID: 20040915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
    Chakrabarty M; Jha AN; Sharma DJ
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.
    McGlinchey AJ; Govaere O; Geng D; Ratziu V; Allison M; Bousier J; Petta S; de Oliviera C; Bugianesi E; Schattenberg JM; Daly AK; Hyötyläinen T; Anstee QM; Orešič M
    JHEP Rep; 2022 May; 4(5):100477. PubMed ID: 35434590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The clinical implications of pre-liver transplant diabetes on post-liver transplant outcomes in patients with NASH: analysis of the UNOS database.
    Lee DU; Han J; Lee KJ; Kwon J; Fan GH; Jung D; Urrunaga NH
    Hepatol Int; 2022 Dec; 16(6):1448-1457. PubMed ID: 36088499
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peri-transplant renal dysfunction in patients with non-alcoholic steatohepatitis undergoing liver transplantation.
    Maiwall R; Gupta M
    Transl Gastroenterol Hepatol; 2020; 5():18. PubMed ID: 32258522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-alcoholic steatohepatitis in liver transplant recipients diagnosed by serum cytokeratin 18 and transient elastography: A prospective study.
    Alhinai A; Qayyum-Khan A; Zhang X; Samaha P; Metrakos P; Deschenes M; Wong P; Ghali P; Chen TY; Sebastiani G
    World J Hepatol; 2021 Dec; 13(12):2179-2191. PubMed ID: 35070018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.